Grove Biopharma, Inc. | $30,000,000 | (Apr 25, 2025)
Northwood | $30,000,000 | (Apr 25, 2025)
Steadily Insurance Company | $30,000,000 | (Apr 25, 2025)
Sano Genetics
United Kingdom
- Cambridge, England
- 28/03/2022
- Series A
- $11,000,000
At Sano, our mission is to accelerate the future of personalised medicine.
Our patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost.
Sano's end-to-end Platform integrates with your existing providers and partners, including sites, medical record retrieval services, sample collection and data analysis partners, and we apply our expert knowledge to identify new and highly efficient channels for finding and engaging the patients you need to support your project.
- Industry Biotechnology
- Website https://sanogenetics.com/
- LinkedIn https://www.linkedin.com/company/sanogenetics/
Related People
Patrick ShortCo Founder
United Kingdom -
Greater Cambridge Area
Interested in research in genomics and personalised medicine, particularly rare genetic disorders. Co-founder/CEO of Sano Genetics, a startup providing access to dynamic health and genetic data for research in genomics while promoting transparency and data privacy for participants.
Alternative Payments | $22,000,000 | (Apr 25, 2025)
Listen Labs | $27,000,000 | (Apr 25, 2025)
Lace | $14,000,000 | (Apr 25, 2025)
RISE® Robotics | $1,500,000 | (Apr 25, 2025)
Ravenna | $15,000,000 | (Apr 25, 2025)
ChEmpower Corporation | $18,700,000 | (Apr 25, 2025)
Theo | $20,000,000 | (Apr 25, 2025)
Isembard | $9,000,000 | (Apr 25, 2025)
Electra(US) | $186,000,000 | (Apr 25, 2025)